Dr. Mark Lewis talks about mitochondrial medicine, photobiomodulation, and regenerative care you can scale

In this episode of Innovators of Health, Dr. Mark Lewis explains why the future of regenerative care starts at the mitochondria—and how photobiomodulation (red/NIR light) fits into evidence-guided protocols that improve recovery, reduce pain, and extend care from clinic to home. He breaks down wavelength/dose fundamentals (with patient-friendly analogies), shares outcomes from integrating RedVive into treatment packages, and outlines the mindset shift clinicians need to adopt energy-based therapies ethically, effectively, and at scale.Key Takeaways (with emojis)🔴 Energy-first healing: PBM boosts mitochondrial ATP—better inputs, better recovery.🧪 Science, not hype: Class II device, studied wavelengths + dosing you can standardize.🧠 Mindset shift: Evaluate new tech with protocols and metrics—not marketing.🧰 Stack & scale: Pair PBM with regenerative/rehab plans for additive outcomes.🏠 Clinic → home: Simple at-home routines extend benefits and adherence.🗣️ Teach simply: Clear analogies turn complex cellular concepts into “I get it.”🙋 Walk the walk: Clinician self-use builds credibility and patient trust.🎯 Set expectations: Outcomes vary—dose, timing, and consistency matter.To learn more about red light therapy and photobiomodulation, visit us at redvivehealth.orgThis podcast is hosted by Dr. Rahul Desai and Jaydev Karande.Watch all of our Innovators of Health Video Episodes at:https://www.youtube.com/@InnovatorsofHealthLearn more at Red Light Therapy at redvivehealth.org